NuCana (NCNA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.99, -2.93% vs the prior close of $1.02.
- Volume 46.27K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NCNA dips 2.9% to $0.99, a 52-week low, 7 down days in a row. Closed at $0.99, -2.93% vs the prior close of $1.02. Day range $0.97β$1.03, opened at $1.02.
NCNA daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β NCNA dips 2.9% to $0.99, a 52-week low, 7 down days in a row
- Closed at $0.99, -2.93% vs the prior close of $1.02. Day range $0.97β$1.03, opened at $1.02.
- Volume was 46.27K shares, 0.3x its 50-day average of 146.46K β lighter than usual.
- Price is -25.8% vs its 50-day average ($1.33) and -47.3% vs its 200-day average ($1.88).
- 52-week range $0.95β$5.65; today's close sits at 1% of that range, 82.5% below the 52-week high.
- That makes 7 straight losses.
Oct 15, 2026 β NCNA dips 2.9% to $1.02, a 52-week low, 6 down days in a row
- Closed at $1.02, -2.86% vs the prior close of $1.05. Day range $0.97β$1.04, opened at $1.02.
- Volume was 55.10K shares, 0.4x its 50-day average of 145.87K β lighter than usual.
- Price is -23.9% vs its 50-day average ($1.34) and -46.0% vs its 200-day average ($1.89).
- 52-week range $0.95β$6.10; today's close sits at 1% of that range, 83.3% below the 52-week high.
- That makes 6 straight losses.
Oct 14, 2026 β NCNA ends flat (+0.0%) to $1.05, 5 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.03β$1.07, opened at $1.05.
- Volume was 38.00K shares, 0.3x its 50-day average of 145.33K β lighter than usual.
- Price is -22.1% vs its 50-day average ($1.35) and -44.8% vs its 200-day average ($1.90).
- 52-week range $0.95β$6.10; today's close sits at 2% of that range, 82.8% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 β NCNA dips 2.8% to $1.05, a 52-week low, 4 down days in a row
- Closed at $1.05, -2.78% vs the prior close of $1.08. Day range $1.05β$1.10, opened at $1.10.
- Volume was 52.00K shares, 0.4x its 50-day average of 144.83K β lighter than usual.
- Price is -22.5% vs its 50-day average ($1.35) and -45.1% vs its 200-day average ($1.91).
- 52-week range $0.95β$6.16; today's close sits at 2% of that range, 83.0% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 β NCNA dips 1.8% to $1.08, 3 down days in a row
- Closed at $1.08, -1.82% vs the prior close of $1.10. Day range $1.08β$1.14, opened at $1.10.
- Volume was 28.60K shares, 0.2x its 50-day average of 144.75K β lighter than usual.
- Price is -20.6% vs its 50-day average ($1.36) and -43.9% vs its 200-day average ($1.92).
- 52-week range $0.95β$6.17; today's close sits at 3% of that range, 82.5% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 β NCNA dips 2.7% to $1.10
- Closed at $1.10, -2.65% vs the prior close of $1.13. Day range $1.07β$1.18, opened at $1.13.
- Volume was 67.40K shares, 0.5x its 50-day average of 143.58K β lighter than usual.
- Price is -19.4% vs its 50-day average ($1.37) and -43.2% vs its 200-day average ($1.94).
- 52-week range $0.95β$6.40; today's close sits at 3% of that range, 82.8% below the 52-week high.
Oct 8, 2026 β NCNA dips 0.9% to $1.13
- Closed at $1.13, -0.88% vs the prior close of $1.14. Day range $1.10β$1.14, opened at $1.14.
- Volume was 34.60K shares, 0.2x its 50-day average of 143.45K β lighter than usual.
- Price is -17.4% vs its 50-day average ($1.37) and -42.0% vs its 200-day average ($1.95).
- 52-week range $0.95β$6.65; today's close sits at 3% of that range, 83.0% below the 52-week high.
Oct 7, 2026 β NCNA jumps 4.6% to $1.14
- Closed at $1.14, +4.59% vs the prior close of $1.09. Day range $1.06β$1.18, opened at $1.11.
- Volume was 51.00K shares, 0.4x its 50-day average of 142.68K β lighter than usual.
- Price is -16.8% vs its 50-day average ($1.37) and -41.8% vs its 200-day average ($1.96).
- 52-week range $0.95β$7.22; today's close sits at 3% of that range, 84.2% below the 52-week high.
Oct 6, 2026 β NCNA rises 2.8% to $1.09
- Closed at $1.09, +2.83% vs the prior close of $1.06. Day range $1.05β$1.14, opened at $1.08.
- Volume was 50.90K shares, 0.4x its 50-day average of 142.20K β lighter than usual.
- Price is -20.6% vs its 50-day average ($1.37) and -44.7% vs its 200-day average ($1.97).
- 52-week range $0.95β$7.22; today's close sits at 2% of that range, 84.9% below the 52-week high.
Oct 5, 2026 β NCNA dips 2.8% to $1.06, a 52-week low, 3 down days in a row
- Closed at $1.06, -2.75% vs the prior close of $1.09. Day range $1.03β$1.12, opened at $1.12.
- Volume was 70.30K shares, 0.5x its 50-day average of 140.88K β lighter than usual.
- Price is -23.0% vs its 50-day average ($1.38) and -46.5% vs its 200-day average ($1.98).
- 52-week range $0.95β$7.22; today's close sits at 2% of that range, 85.3% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 β NCNA slides 6.8% to $1.09, a 52-week low on 2.4x normal volume
- Closed at $1.09, -6.84% vs the prior close of $1.17. Day range $0.95β$1.22, opened at $1.18.
- Volume was 320.90K shares, 2.4x its 50-day average of 134.87K β unusually heavy trading.
- Price is -21.1% vs its 50-day average ($1.38) and -45.4% vs its 200-day average ($2.00).
- 52-week range $0.95β$7.22; today's close sits at 2% of that range, 84.9% below the 52-week high.
NCNA latest news & SEC filings
Every SEC filing by or about NCNA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 24, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade NCNA
- How much it moves: over the last 20 sessions the average daily move was 3.52% (largest 13.3%). That is a volatile stock.
- Liquidity: about 254.38K shares (β$251.87K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.99 vs a range of $0.95β$5.65 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:200 on Aug 11, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 30, 2026; 6-K Aug 13, 2026; 6-K Jun 8, 2026.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
NCNA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.02 | 1.03 | 0.97 | 0.99 | 46.27K |
| Oct 15, 2026 | 1.02 | 1.04 | 0.97 | 1.02 | 55.10K |
| Oct 14, 2026 | 1.05 | 1.07 | 1.03 | 1.05 | 38.00K |
| Oct 13, 2026 | 1.10 | 1.10 | 1.05 | 1.05 | 52.00K |
| Oct 12, 2026 | 1.10 | 1.14 | 1.08 | 1.08 | 28.60K |
| Oct 9, 2026 | 1.13 | 1.18 | 1.07 | 1.10 | 67.40K |
| Oct 8, 2026 | 1.14 | 1.14 | 1.10 | 1.13 | 34.60K |
| Oct 7, 2026 | 1.11 | 1.18 | 1.06 | 1.14 | 51.00K |
| Oct 6, 2026 | 1.08 | 1.14 | 1.05 | 1.09 | 50.90K |
| Oct 5, 2026 | 1.12 | 1.12 | 1.03 | 1.06 | 70.30K |
| Oct 2, 2026 | 1.18 | 1.22 | 0.95 | 1.09 | 320.90K |
| Oct 1, 2026 | 1.29 | 1.31 | 1.01 | 1.17 | 799.10K |
| Sep 30, 2026 | 1.29 | 1.44 | 1.26 | 1.35 | 3.30M |
| Sep 29, 2026 | 1.29 | 1.29 | 1.21 | 1.21 | 24.70K |
| Sep 28, 2026 | 1.32 | 1.37 | 1.26 | 1.29 | 23.60K |
| Sep 25, 2026 | 1.30 | 1.35 | 1.21 | 1.28 | 38.20K |
| Sep 24, 2026 | 1.31 | 1.34 | 1.27 | 1.32 | 9.20K |
| Sep 23, 2026 | 1.33 | 1.35 | 1.30 | 1.31 | 27.80K |
| Sep 22, 2026 | 1.35 | 1.38 | 1.30 | 1.33 | 20.40K |
| Sep 21, 2026 | 1.35 | 1.39 | 1.32 | 1.32 | 25.30K |
About NuCana
NuCana (NCNA) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in EDINBURGH, United Kingdom. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 1709626.
NCNA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Hugh Griffith | Chief Executive Officer | Mar 18, 2026 |
| Andrew Martin Kay | Director | Mar 18, 2026 |
| Cyrille Leperlier | Director | Mar 18, 2026 |
| Elliott M. Levy | Director | Jun 24, 2026 |
| Martin C.B. Mellish | Director | Mar 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeffrey D. Bloss | Chief Medical Officer | Jun 23, 2026 |
| Theresa Margaret Ms Bruce | Chief Operating Officer | Apr 16, 2026 |
| Hugh Griffith | Chief Executive Officer | Mar 18, 2026 |
| David James Harrison | Head of Translational Medicine | Mar 24, 2026 |
| Ian Alexander Webster | See Remarks | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NCNA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
NCNA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NCNA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.